NA
PLXP

Nottingham Advisors’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Nottingham Advisors’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-58,584
Closed -$422K – 111
2019
Q2 		$422K Buy
+58,584
New +$318K 0.06% 79

Other funds holding PLXP

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HWA
Heritage Way Advisors Rockford, Illinois $267M AUM 23.86% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CWM
Cranbrook Wealth Management Bloomfield Hills, Michigan $492M AUM 14.37% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Nottingham Advisors's PLXP Position: Q3 2019 in Review

Nottingham Advisors sold out of PLx Pharma Inc. Common Stock (PLXP) in Q3 2019, closing a stake of 58,584 shares — an estimated $422K sold.

Nottingham Advisors first reported a position in PLXP in Q2 2019 and held it in 1 quarter. The position peaked at $422K in Q2 2019. 16 funds tracked by Wall St. Rank hold PLXP as of Q3 2019.

  • Nottingham Advisors reported no remaining PLx Pharma Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Nottingham Advisors sold 58,584 PLx Pharma Inc. Common Stock shares in Q3 2019, an estimated $422K.
  • Nottingham Advisors first reported a position in PLx Pharma Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • Nottingham Advisors's PLx Pharma Inc. Common Stock position peaked at $422K in Q2 2019.
  • 16 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q3 2019.

Based on Nottingham Advisors's 13F filing for Q3 2019, filed 11 Oct 2019.